DHR · Danaher Corp
Price
Snapshot
50 fields · last close| Market Cap | $148.4B |
| P/E | 36.77 |
| Float | 626.6M |
| Beta | 0.79 |
| Volatility | 19.8% |
| Exchange | NYSE |
| Sector | Life Sciences Tools & Services |
| Cap tier | Large cap |
| Macro sensitivity | Moderate |
| Clavix score | 75 |
| Price | 206.78 |
| Change | −2.01% |
| Prev Close | 211.03 |
| Open | 210.51 |
| Day Low | 206.05 |
| Day High | 213.13 |
| Avg Vol | 3 |
| Avg $ Vol | $698.1M |
| 52W High | 242.80 |
| 52W Low | 160.93 |
| 52W Pos | 56.0% |
| From High | −14.84% |
| From Low | +28.49% |
| Max DD 1Y | −33.11% |
| Spread | 0.10% |
| Liquidity | Deep |
| SMA 20 | −1.58% |
| SMA 50 | +2.70% |
| SMA 200 | +2.03% |
| RSI (14) | 55.0 |
| Vol 30D | 28.0% |
| Vol 90D | 36.1% |
| 1Y Range | 161–243 |
| Daily bars | 507 |
| Perf Week | −2.16% |
| Perf Month | +5.69% |
| Perf Quarter | +13.07% |
| Perf Half Y | +7.94% |
| Perf Year | +6.03% |
| Perf YTD | −10.25% |
| Prev Day | −2.01% |
| Clavix | B |
| Debt / Eq | 0.35 |
| Curr Ratio | 1.87 |
| Int Cover | 13.3× |
| FCF Margin | 21.4% |
| Rev Growth | +0.0% |
| Profit | Profitable |
| Leverage | Low |
| Sector rank | 6 / 19 |
What DHR does
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.
The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions.
The Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands.
The Diagnostics segment offers clinical instruments, consumables, software, and services that hospitals, physicians’ offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions.
The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984.
Danaher Corporation was incorporated in 1969 and is headquartered in Washington, the District Of Columbia.
Clavix risk grade
regraded every trading dayDHR grades B, 75 of 100. Steadiest on News Sentiment (67), most exposed on Price Stability (60, mixed). 2 of the 4 weighted dimensions sit above the Life Sciences Tools & Services median. Ranks 6 of 19 in Life Sciences Tools & Services by Clavix score.
How rough the ride is
| DHR | Life Sciences Tools & Services median | |
|---|---|---|
| Betavs the overall market · lower is steadier | 0.79 | 1.19 |
| Volatilityannualized | 19.8% | 29.7% |
| Max drawdown, past yearworst peak-to-trough fall | −33.1% | — |
| Typical daily movemedian absolute daily change | 1.04% | — |
| Days beyond ±3%of the last 252 sessions | 208% | — |
How its days are spread
Daily returns over the last 252 sessions in 1% bins. Moves beyond ±6% land in the end bins.
52-week range
The bar runs from the lowest to the highest close of the last 252 sessions; the marker is the latest close.
Drawdown from the 1-year peak
Percent below the running high over the last 12 months. Zero is a fresh high.
Market sensitivity
| DHR | Life Sciences Tools & Services median | |
|---|---|---|
| Beta to the markethow much it swings with the S&P 500 · lower is safer | 0.79 | 1.19 |
| Macro sensitivityrate, dollar and credit exposure bucket | Moderate | Moderate47% of 19 |
Where it sits on the macro scale
Low means rates, the dollar and credit spreads barely move it. Very High means they drive a large share of its swings. The counts are how many Life Sciences Tools & Services names sit in each bucket.
Where it ranks in its sector
Rank by Clavix score within the sector. Right is the top of the sector.
Price performance
| DHR | |
|---|---|
| 1 week | −2.2% |
| 1 month | +5.7% |
| Year to date | −10.3% |
| 1 year | +6.0% |
Context for the rank, not itself a risk measure.
Recent coverage, scored
| DHR | |
|---|---|
| Articles scoredthe most recent scored coverage, up to 30 | 30since 16 Jul |
| Average score0 most bearish, 100 most bullish | 57 |
| Bullish · bearisharticles above 60 · below 40 | 17 · 5 |
| Directionarticles whose tone is improving vs worsening | 17 ↑ 5 ↓ |
Where the article scores land
Each bar is a 10-point band of article scores. Below 40 reads bearish, above 60 bullish.
Balance sheet, against the sector
The shaded band is the middle half of the 19 Life Sciences Tools & Services names Clavix covers; the tick is the sector median.
Growth
| DHR | |
|---|---|
| Revenue growthyear over year | +0.0% |
Financial Health is shown but does not count toward the grade. Why
0–100, higher is safer. The tick on each bar is the Life Sciences Tools & Services median. Click a dimension for the evidence behind it. Financial Health is shown but does not count toward the grade.
Against Life Sciences Tools & Services
19 companies| Metric | DHR | Sector spread | Median |
|---|---|---|---|
| Beta | 0.79 | 1.19 | |
| Volatility | 19.8% | 29.7% | |
| P/E | 36.77 | 36.77 | |
| Debt / equity | 0.35 | 0.51 | |
| Current ratio | 1.87 | 1.89 | |
| FCF margin | 21.4% | 19.5% | |
| Interest coverage | 13.3× | 3.5× |
Recent news
most recent scored articles · the chip is the article’s score · click to openMan Group plc disclosed in a recent SEC Form 13F filing that it opened a new position in Danaher Corporation during the second quarter, buying 428,118 shares valued at roughly $81.55 million.
Danaher's Biotechnology segment is growing, supported by demand from China, strength in bioprocessing (the equipment used to manufacture biologic drugs), and improving discovery markets, though regional headwinds are partially offsetting that growth.
B. Metzler seel. Sohn & Co. AG disclosed in its most recent 13F filing (a quarterly SEC report of investment holdings) that it acquired a new position in Danaher Corporation in the second quarter, buying 28,281 shares worth about $20.36 million. The article body is cut off after this detail.
A Delaware jury awarded Beckman Coulter roughly $36 million in damages after finding that Cytek Biosciences infringed a Beckman Coulter patent covering technology that quickly analyzes single cells.
Madison Asset Management bought a new position in Danaher, acquiring 448,611 shares worth about $85.45 million in the second quarter, making DHR roughly 1.0% of its portfolio.
Nearest peers by size
Life Sciences Tools & Services| Ticker | Company | Grade | Mkt cap | P/E | Beta | |
|---|---|---|---|---|---|---|
| TMO | Thermo Fisher Scientific Inc | B+ | $228.7B | 32.51 | 0.87 | Compare |
| IQV | IQVIA Holdings Inc | B- | $44.71B | 32.10 | 1.18 | Compare |
| A | Agilent Technologies Inc | B | $42.28B | 29.65 | 1.27 | Compare |
| WAT | Waters Corp | B | $37.34B | 243.61 | 1.19 | Compare |
| ILMN | Illumina Inc | B- | $33.47B | 39.20 | 1.48 | Compare |
| MTD | Mettler-toledo International Inc | B+ | $27.17B | 29.97 | 1.21 | Compare |
| WST | West Pharmaceutical Services Inc | B+ | $23.90B | 42.69 | 1.16 | Compare |
| MEDP | Medpace Holdings Inc | B- | $16.56B | 33.64 | 1.13 | Compare |
You just read one holding. Clavix reads the whole portfolio.
Every position you own, graded on the same five dimensions, with an alert when a grade moves. Three months free on iPhone.